3rd Oral Drug to Treat MS Is Approved by the F.D.A.

Thursday, March 28, 2013 - 03:10 in Health & Medicine

Wall Street analysts, doctors and patients expect Tecfidera to become a blockbuster because of its efficacy, relative safety and convenience.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net